Inventor · disambiguated record
Wai Ngor Chan
Also filed as: CHAN WAI N · CHAN WAI NGOR
15 granted patents·11 pending applications·59 citations·filing 1993–2009
91Inventor score
Files withSMITHKLINE BEECHAM PLC14SMITHKLINE BEECHAM LTD5GLAXO GROUP LTD4BERTHELEME NICOLAS1SMITHKLINE BEECHAM CORP1
Top patents by PatentIndex Score
26 records- 0184US7943645B2Piperidine compounds for use as orexin receptor antagonistSMITHKLINE BEECHAM LTD·Filed 2008·Granted May 17, 2011·7 cites·8 claims
- 0278US7423052B2Piperidine compounds for use as orexin receptor antagoinstSMITHKLINE BEECHAM PLC·Filed 2002·Granted Sep 9, 2008·11 cites·15 claims
- 0373US7893090B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Feb 22, 2011·1 cites·11 claims
- 0471US7470710B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Dec 30, 2008·4 cites·17 claims
- 0571US7078565B2Benzamide derivatives as antagonists of orexin receptorsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Jul 18, 2006·7 cites·25 claims
- 0669US2010099752A1Pharmaceutical composition containing bicyclic type compoundsSMITHKLINE BEECHAM PLC·Filed 2009·Application pending·0 cites
- 0763US7928125B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Apr 19, 2011·0 cites·8 claims
- 0863US7928124B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Apr 19, 2011·0 cites·6 claims
- 0963US7897618B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Mar 1, 2011·0 cites·7 claims
- 1060US2007088064A1Pharmaceutical composition containing bicyclic type compoundsSMITHKLINE BEECHAM PLC·Filed 2006·Application pending·0 cites
- 1152US2003236410A1Pharmaceutical composition containing bicyclic type compoundsSMITHKLINE BEECHAM PLC·Filed 2003·Application pending·0 cites
- 1250US6211211B1Benzopyrans and their use as therapeutic agentsSMITHKLINE BEECHAM PLC·Filed 1998·Granted Apr 3, 2001·9 cites·18 claims
- 1349US2002123630A1Pharmaceutical composition containing bicyclic type compoundsSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 1448US2001021780A1Pharmaceutical composition containing bicyclic type compoundsSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 1547US5948811APharmaceutical composition containing bicyclic type compoundsSMITHKLINE BEEGHAM P L C·Filed 1997·Granted Sep 7, 1999·11 cites·9 claims
- 1647US2007142431A1Quinoline 4-carboxamide derivatives and their use as neurokinin 3 (nk-3) receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 2004·Application pending·0 cites
- 1744US8173820B2Compounds which potentiate the AMPA receptor and uses thereof in medicineBERTHELEME NICOLAS·Filed 2008·Granted May 8, 2012·0 cites·9 claims
- 1844US2010137276A1Compounds which potentiate ampa receptor and uses thereof in medicineGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 1940US2008255144A1Acylated Piperidines as Glycine Transporter InhibitorsGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 2040US2009270510A1Glycine transport inhibitorsGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 2139US5760074ATreatmentSMITHKLINE BEECHAM PLC·Filed 1995·Granted Jun 2, 1998·4 cites·6 claims
- 2239US2008090822A1Piperazine Derivatives As Glyt 1 InhibitorsGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 2338US2001027248A1Novel receptorSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 2435US5908860ABicyclic compounds with pharmaceutical activitySMITHKLINE BEECHAM PLC·Filed 1993·Granted Jun 1, 1999·3 cites·2 claims
- 2531US6245893B1Receptor that binds anti-convulsant compoundsSMITHKLINE BEECHAM PLC·Filed 1999·Granted Jun 12, 2001·1 cites·2 claims
- 2627US5985334AScreening methods to identify anti-convulsant compoundsSMITHKLINE BEECHAM PLC·Filed 1995·Granted Nov 16, 1999·1 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Wai Ngor Chan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →